Vitestro

About Vitestro

Vitestro develops an autonomous blood drawing device that utilizes AI-based, ultrasound-guided imaging and robotic needle insertion to automate the entire blood collection process. This technology addresses the shortage of healthcare personnel by increasing the efficiency and availability of blood drawing services in hospitals, allowing patients to receive timely diagnostics on their own schedule.

```xml <problem> The increasing shortage of healthcare personnel strains the availability and efficiency of blood drawing services, a critical component of clinical diagnostics. This can lead to delays in diagnosis and treatment, impacting patient care and outcomes. </problem> <solution> Vitestro is developing an autonomous blood drawing device that automates the entire blood collection process, from tourniquet application to bandage placement. The device utilizes AI-based, ultrasound-guided imaging and robotic needle insertion to ensure accurate and secure blood collection. By automating the blood drawing workflow, Vitestro aims to increase the efficiency and availability of blood drawing services, reducing the workload on healthcare personnel and empowering patients to receive timely diagnostics on their own schedule. The device is designed to be intuitive and can be used under supervision by a wide range of patients. </solution> <features> - AI-based, ultrasound-guided imaging for vein localization - Robotic needle insertion for precise and automated blood collection - Fully automated procedure, including tourniquet and bandage application - Standardized blood drawing process to ensure consistent quality - Continuous operation to boost the availability of blood drawing services - Designed for a high level of patient safety and reduced anxiety - CE Marking, acknowledging the device meets the requirements of the European Medical Device Regulation (MDR) </features> <target_audience> The primary target audience includes hospitals, clinical laboratories, and healthcare providers seeking to improve the efficiency and availability of blood drawing services while addressing staffing shortages. </target_audience> ```

What does Vitestro do?

Vitestro develops an autonomous blood drawing device that utilizes AI-based, ultrasound-guided imaging and robotic needle insertion to automate the entire blood collection process. This technology addresses the shortage of healthcare personnel by increasing the efficiency and availability of blood drawing services in hospitals, allowing patients to receive timely diagnostics on their own schedule.

Where is Vitestro located?

Vitestro is based in Utrecht, The Netherlands.

When was Vitestro founded?

Vitestro was founded in 2017.

How much funding has Vitestro raised?

Vitestro has raised $34.0.

Location
Utrecht, The Netherlands
Founded
2017
Funding
$34.0
Employees
114 employees
Investors
Sonder CapitalInvest-NLNybc Ventures

Vitestro

10
Relative Traction Score based on online presence metrics compared to companies in the same age group.

Executive Summary

Vitestro develops an autonomous blood drawing device that utilizes AI-based, ultrasound-guided imaging and robotic needle insertion to automate the entire blood collection process. This technology addresses the shortage of healthcare personnel by increasing the efficiency and availability of blood drawing services in hospitals, allowing patients to receive timely diagnostics on their own schedule.

vitestro.com5K+
Founded 2017 – Utrecht, Netherlands

Funding

Series A

Announced on March 1, 2023

$12.0

Investors: MedTech Innovator

Series B

Announced on April 1, 2024

$22.0

Investors: Invest-NL, Nybc Ventures, Sonder Capital, European Innovation Council Fund

Total Funding

$34.0

Backed by

European Innovation Council FundInvest-NLMedTech InnovatorNybc VenturesSonder Capital

Team (100+)

No team information available.

Company Description

Problem

The increasing shortage of healthcare personnel strains the availability and efficiency of blood drawing services, a critical component of clinical diagnostics. This can lead to delays in diagnosis and treatment, impacting patient care and outcomes.

Solution

Vitestro is developing an autonomous blood drawing device that automates the entire blood collection process, from tourniquet application to bandage placement. The device utilizes AI-based, ultrasound-guided imaging and robotic needle insertion to ensure accurate and secure blood collection. By automating the blood drawing workflow, Vitestro aims to increase the efficiency and availability of blood drawing services, reducing the workload on healthcare personnel and empowering patients to receive timely diagnostics on their own schedule. The device is designed to be intuitive and can be used under supervision by a wide range of patients.

Features

AI-based, ultrasound-guided imaging for vein localization

Robotic needle insertion for precise and automated blood collection

Fully automated procedure, including tourniquet and bandage application

Standardized blood drawing process to ensure consistent quality

Continuous operation to boost the availability of blood drawing services

Designed for a high level of patient safety and reduced anxiety

CE Marking, acknowledging the device meets the requirements of the European Medical Device Regulation (MDR)

Target Audience

The primary target audience includes hospitals, clinical laboratories, and healthcare providers seeking to improve the efficiency and availability of blood drawing services while addressing staffing shortages.

Sources:

1
This profile is AI-generated from web data and may contain inaccuracies. Want to correct or remove an entry? Owners can claim edits via their company email domain, and signed-in users can submit sourced suggestions.